Supplemental Material 1

Total Page:16

File Type:pdf, Size:1020Kb

Supplemental Material 1 Supplemental gure 1 Lin-Sca-1- Marker Thymus Bone Skin 41% ±1 64% ±8 92% ±4 CD29 % of max % of max % of max 50% ±10 58% ±9 87% ±4 CD51 % of max % of max % of max 3% ±1 47% ±3 72% ±7 CD140a % of max % of max % of max 39% ±6 51% ±3 71% ±3 CD140b % of max % of max % of max 4% ±2 1% ±1 7% ±1 CD34 % of max % of max % of max 21% ±16 30% ±10 42% ±10 gp38 % of max % of max % of max 50% ±4 43% ±7 55% ±5 Ly51 % of max % of max % of max 49% ±3 8% ±1 73% ±6 CD90.2 % of max % of max % of max 36% ±10 35% ±10 77% ±5 CD105 % of max % of max % of max 2% ±2 47% ±8 78% ±6 CD73 % of max % of max % of max 9% ±8 8% ±3 38% ±2 CD44 % of max % of max % of max 48% ±3 27% ±1 52% ±4 CD146 % of max % of max % of max 17% ±13 11% ±8 28% ±7 Nestin % of max % of max % of max 6% ±5 23% ±29 37% ±25 CXCL12 % of max % of max % of max SUPPLEMENTAL FIGURE 1. Flow cytometry analysis of Lin- Sca-1- cells from the thymus, bone and skin. Overlay histograms illustrate staining with the relevant antibody (in blue) and an isotype control (in red). Each overlay histogram is representative of three independent experiments (3-5 mice per biological replicate). Numbers represent the mean percentage of positive cells (+/- SD). Supplemental gure 2 A B 1000 250k M 100 tMC 98.2% K P bMC 200k R 10 sMC 1 A - 150k 1 9 1 a 4 8 1 0 5 A 2 5 0 3 3 5 9 0 C S CD CD CD gp Ly CD CD1 FSC 100k CD14 CD140b 1000 tMC 50k bMC M 100 sMC K 0 P Thymocytes R 10 -103 0 103 104 105 cTEC 1 mTEC SCA-1 t 5 e 1 m 1 i 4 3 3 n -k ca x c CD CD CD p o E F C tMC vs bMC tMC vs sMC bMC vs sMC 7 7 ) ) ) 6 695 6 6 365 5 426 sMC sMC bMC 5 5 4 4 4 3 3 3 2 2 2 (ReadCount (ReadCount 362 10 10 1 849 1 1 573 log log 0 log10(ReadCount 0 r = 0.476 0 r = 0.629 r = 0.607 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 log (ReadCount tMC) log10(ReadCount bMC) log10(ReadCount tMC) 10 SUPPLEMENTAL FIGURE 2. Purity of cell populations used for RNA-Seq analyses. (A) Post-sort analysis of sorted Sca-1+ thymic MCs. (B) Upper panel, histogram depicting the expression levels (RPKM) of 10 typical MC markers in the Sca-1+ MCs from the thymus, bone and skin. Lower panel, histogram showing expression levels of genes expressed in thymocytes or TECs. (RPKM = 15; red line) (C) Scatterplots depicting the number of DEGs in each one-to-one comparison of MC populations. Numbers in bold represent the amount of DEGs associated to the respective MC population in each comparison. Pearson correlation value (r) is also depicted in the bottom right corner of each scatterplot. Supplemental figure 3 C1 - Thymus C2 - Bone Z-score Z-score 0 1 2 3 4 5 0 2 4 6 8 quantity of cells (113) quantity of blood cells (82) B migration of cells (145) quantity of leukocytes (77) leukocyte migration (125) cell movement (153) cell movement of lymphocytes (25) cell movement of leukocytes (107) cell movement of cell movement of myeloid cells (77) mononuclear leukocytes (28) Lymphocyte migration (23) cell movement of phagocytes (81) leukocyte migration (48) A cell movement of neutrophils (56) A cell movement of leukocytes (44) recruitment of phagocytes (42) migration of phagocytes (13) chemotaxis of leukocytes (53) migration of antigen presenting cells (10) chemotaxis of phagocytes (45) cell movement of antigen (21) cell movement of presenting cells mononuclear leukocytes (51) migration of phagocytes (37) orientation of cells (8) C infiltration of leukocytes (51) 0 5 10 15 20 infiltration of cells (56) - log P-value ( ) cell movement of antigen (38) 10 presenting cells inflammatory response (95) D C3 - Skin proliferation of cells (183) E Z-score 0 1 2 3 4 angiogenesis (52) vascularization (25) B recruitment of myeloid cells (11) recruitment of cells (14) A internalization of cells (20) F recruitment of phagocytes (11) activation of myeloid cells (31) 2.4 2.6 2.8 3.0 3.2 3.4 C activation of neutrophils (12) - log10 P-value ( ) 0 10 20 30 40 50 ( ) - log10 P-value C4 - Thymus + Bone C6 - Bone + Skin Z-score Z-score 0 5 10 15 0 5 10 15 size of body (27) differentiation of connective (21) B tissue cells B differentiation of cells (58) proliferation of cells (75) C transcription of DNA (29) development of (34) activation of DNA (26) C cardiovascular system endogenous promoter vasculogenesis (27) A angiogenesis (30) fertility (13) E 0 2 4 6 cell viability (21) - log10 P-value ( ) F vasculogenesis (22) D angiogenesis (25) C5 - Thymus + Skin Z-score cell movement (45) 0 2 4 6 cell movement of myeloid cells (22) cell movement of phagocytes (18) migration of cells (20) A cell movement of cell movement of granulocytes (13) myeloid cells (8) A migration of myeloid cells (9) cell movement (8) of phagocytes migration of granulocytes (7) size of body (13) B development of body axis (33) G quantity of cells (21) C proliferation of epithelial cells (17) H differentiation of cells (30) D adhesion of immune cells (10) I 2.0 2.5 3.0 3.5 4.0 0 1 2 3 4 - log10 P-value ( ) - log10 P-value ( ) SUPPLEMENTAL FIGURE 3. Core biological functions associated to the 6 DEG clusters. All functions depicted in histograms were signifcantly enriched (p < 0.05) and activated (Z-score > 2). Related functions were clustered (letters). Numbers in parentheses represent the number of genes per biological functions. Red/black dots represent p-values. Supplemental table 1 # Gene symbol Gene name # Gene symbol Gene name 1 1700048O20Rik RIKEN cDNA 1700048O20 gene 40 Ccl7 chemokine (C-C motif) ligand 7, MCP3 2 2610524H06Rik RIKEN cDNA 2610524H06 gene 41 Cd248 CD248 antigen, endosialin 3 4930452B06Rik RIKEN cDNA 4930452B06 gene 42 Cdk18 cyclin-dePendent kinase 18 4 A4galt alPha 1,4-galactosyltransferase 43 Cdkn1c cyclin-dePendent kinase inhibitor 1C; P57KiP2 5 Acpl2 acid PhosPhatase-like 2 44 Cdkn2b cyclin-dePendent kinase inhibitor 2B (P15, inhibits CDK4) 6 Adam12 a disintegrin and metalloPePtidase domain 12 (meltrin alPha) 45 Cdyl2 chromodomain Protein, Y chromosome-like 2 7 Adam19 a disintegrin and metalloPePtidase domain 19 (meltrin beta) 46 Cep170b centrosomal Protein of 170 kDa Protein B 8 Adam8 a disintegrin and metalloPePtidase domain 8 47 Chst1 carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 a disintegrin-like and metalloPePtidase (reProlysin tyPe) with 9 Adamts12 48 Chst2 carbohydrate sulfotransferase 2 thrombosPondin tyPe 1 motif, 12 a disintegrin-like and metalloPePtidase (reProlysin tyPe) with 10 Adamts2 49 Cib2 calcium and integrin binding family member 2 thrombosPondin tyPe 1 motif, 2 11 Adcy3 adenylate cyclase 3 50 Cldn1 claudin 1 aminoglycoside PhosPhotransferase domain-containing 12 Agphd1 51 Col1a1 collagen, tyPe I, alPha 1 Protein 1 13 Ahr aryl hydrocarbon recePtor 52 Col1a2 collagen, tyPe I, alPha 2 14 Akap2 a-kinase anchor Protein 2 53 Col3a1 collagen, tyPe III, alPha 1 15 Akap6 akap6 Protein 54 Col4a6 collagen, tyPe IV, alPha 6 alkaline PhosPhatase, tissue-nonsPecific isozyme; alkaline 16 Alpl 55 Col6a2 collagen, tyPe VI, alPha 2 PhosPhatase, liver/bone/kidney 17 Angel1 Protein angel homolog 1 56 Coro2a coronin-2A 18 Angptl4 angioPoietin-like 4 57 Crabp1 cellular retinoic acid binding Protein I 19 Aoc3 amine oxidase, coPPer containing 3 58 Creb3l1 cAMP resPonsive element binding Protein 3-like 1 20 Arc activity-regulated cytoskeleton-associated Protein 59 Crip2 cysteine rich Protein 2, CRP-2 21 Arhgap28 rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 60 Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 22 Arhgef28 rho-guanine nucleotide exchange factor 61 Ctsh cathePsin H 23 Arhgef6 rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 62 Ctso cathePsin O 24 Arrb1 beta-arrestin-1 63 Cxcl12 chemokine (C-X-C motif) ligand 12 25 Atp10a ATPase, class V, tyPe 10A 64 Cyp26b1 cytochrome P450, family 26, subfamily b, PolyPePtide 1 UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, 26 B3galnt1 65 Cyp2j6 cytochrome P450 2J6 PolyPePtide 1 27 B4galnt1 beta-1,4 N-acetylgalactosaminyltransferase 1 66 Dclk2 serine/threonine-Protein kinase DCLK2 28 Bach2 transcriPtion regulator Protein BACH2 67 Depdc7 DEP domain containing 7 29 Bmper BMP-binding endothelial regulator Protein 68 Dhrs7 dehydrogenase/reductase (SDR family) member 7 30 Btbd2 Protein Btbd2 69 Dock3 dedicator of cyto-kinesis 3 31 Cables1 CDK5 and Abl enzyme substrate 1 70 Dpysl3 dihydroPyrimidinase-related Protein 3 32 Calcrl calcitonin recePtor-like 71 Dtx3l deltex 3-like (DrosoPhila) 33 Capn6 calPain 6 72 Duoxa1 dual oxidase maturation factor 1 34 Car13 carbonic anhydrase 13 73 Dynap Protein Dynap 35 Car5b carbonic anhydrase 5b, mitochondrial 74 E130311K13Rik RIKEN cDNA E130311K13 gene 36 Casp12 casPase 12 75 Ebf3 early B cell factor 3 37 Cbr2 carbonyl reductase 2 76 Eda ectodysPlasin-A 38 Ccdc80 coiled-coil domain containing 80 77 Efna5 ephrin A5 39 Ccl5 chemokine (C-C motif) ligand 5, RANTES 78 Ehd3 EH-domain containing 3 # Gene symbol Gene name # Gene symbol Gene name eukaryotic translation initiation factor 2C, 4, Protein 79 Eif2c4 120 Il18rap interleukin 18 receptor accessory protein argonaute-4 80 Eif4e3 eukaryotic translation initiation factor 4E member 3 121 Il1r1 interleukin 1 receptor, type I 81 Elfn1 leucine rich repeat and fibronectin type III, extracellular 1 122 Il1rl1 interleukin 1 receptor-like 1 82 Ell2 elongation factor RNA polymerase II 2 123 Il4ra interleukin 4 receptor, alpha 83 Emb embigin 124 Inf2 inverted formin-2 84 En1 homeobox protein engrailed-1 125 Inpp4b inositol polyphosphate-4-phosphatase, type II 85 Epn3 epsin 3 126 Itgb3bp centromere protein R 86 Eya4 eyes absent 4 homolog (Drosophila) 127 Itm2a integral membrane protein 2A 87 Fabp4 fatty acid-binding protein, adipocyte 128 Ivd isovaleryl
Recommended publications
  • Supplemental Figure 1. Vimentin
    Double mutant specific genes Transcript gene_assignment Gene Symbol RefSeq FDR Fold- FDR Fold- FDR Fold- ID (single vs. Change (double Change (double Change wt) (single vs. wt) (double vs. single) (double vs. wt) vs. wt) vs. single) 10485013 BC085239 // 1110051M20Rik // RIKEN cDNA 1110051M20 gene // 2 E1 // 228356 /// NM 1110051M20Ri BC085239 0.164013 -1.38517 0.0345128 -2.24228 0.154535 -1.61877 k 10358717 NM_197990 // 1700025G04Rik // RIKEN cDNA 1700025G04 gene // 1 G2 // 69399 /// BC 1700025G04Rik NM_197990 0.142593 -1.37878 0.0212926 -3.13385 0.093068 -2.27291 10358713 NM_197990 // 1700025G04Rik // RIKEN cDNA 1700025G04 gene // 1 G2 // 69399 1700025G04Rik NM_197990 0.0655213 -1.71563 0.0222468 -2.32498 0.166843 -1.35517 10481312 NM_027283 // 1700026L06Rik // RIKEN cDNA 1700026L06 gene // 2 A3 // 69987 /// EN 1700026L06Rik NM_027283 0.0503754 -1.46385 0.0140999 -2.19537 0.0825609 -1.49972 10351465 BC150846 // 1700084C01Rik // RIKEN cDNA 1700084C01 gene // 1 H3 // 78465 /// NM_ 1700084C01Rik BC150846 0.107391 -1.5916 0.0385418 -2.05801 0.295457 -1.29305 10569654 AK007416 // 1810010D01Rik // RIKEN cDNA 1810010D01 gene // 7 F5 // 381935 /// XR 1810010D01Rik AK007416 0.145576 1.69432 0.0476957 2.51662 0.288571 1.48533 10508883 NM_001083916 // 1810019J16Rik // RIKEN cDNA 1810019J16 gene // 4 D2.3 // 69073 / 1810019J16Rik NM_001083916 0.0533206 1.57139 0.0145433 2.56417 0.0836674 1.63179 10585282 ENSMUST00000050829 // 2010007H06Rik // RIKEN cDNA 2010007H06 gene // --- // 6984 2010007H06Rik ENSMUST00000050829 0.129914 -1.71998 0.0434862 -2.51672
    [Show full text]
  • Supplemental Table S1
    Entrez Gene Symbol Gene Name Affymetrix EST Glomchip SAGE Stanford Literature HPA confirmed Gene ID Profiling profiling Profiling Profiling array profiling confirmed 1 2 A2M alpha-2-macroglobulin 0 0 0 1 0 2 10347 ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7 1 0 0 0 0 3 10350 ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9 1 0 0 0 0 4 10057 ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 1 0 0 0 0 5 10060 ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 1 0 0 0 0 6 79575 ABHD8 abhydrolase domain containing 8 1 0 0 0 0 7 51225 ABI3 ABI gene family, member 3 1 0 1 0 0 8 29 ABR active BCR-related gene 1 0 0 0 0 9 25841 ABTB2 ankyrin repeat and BTB (POZ) domain containing 2 1 0 1 0 0 10 30 ACAA1 acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiol 0 1 0 0 0 11 43 ACHE acetylcholinesterase (Yt blood group) 1 0 0 0 0 12 58 ACTA1 actin, alpha 1, skeletal muscle 0 1 0 0 0 13 60 ACTB actin, beta 01000 1 14 71 ACTG1 actin, gamma 1 0 1 0 0 0 15 81 ACTN4 actinin, alpha 4 0 0 1 1 1 10700177 16 10096 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 0 1 0 0 0 17 94 ACVRL1 activin A receptor type II-like 1 1 0 1 0 0 18 8038 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 1 0 0 0 0 19 8751 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 1 0 0 0 0 20 8728 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 1 0 0 0 0 21 81792 ADAMTS12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 1 0 0 0 0 22 9507 ADAMTS4 ADAM metallopeptidase with thrombospondin type 1
    [Show full text]
  • Structural Characterization of Polysaccharides from Cordyceps Militaris and Their Hypolipidemic Effects Cite This: RSC Adv.,2018,8,41012 in High Fat Diet Fed Mice†
    RSC Advances View Article Online PAPER View Journal | View Issue Structural characterization of polysaccharides from Cordyceps militaris and their hypolipidemic effects Cite this: RSC Adv.,2018,8,41012 in high fat diet fed mice† Zhen-feng Huang, ‡ Ming-long Zhang,‡ Song Zhang,* Ya-hui Wang and Xue-wen Jiang Cordyceps militaris is a crude dietary therapeutic mushroom with high nutritional and medicinal values. Mushroom-derived polysaccharides have been found to possess antihyperglycemic and antihyperlipidemic activities. This study aimed to partially clarify the structural characterization and comparatively evaluate hypolipidemic potentials of intracellular- (IPCM) and extracellular polysaccharides of C. militaris (EPCM) in high fat diet fed mice. Results indicated that IPCM-2 is a-pyran polysaccharide with an average molecular weight of 32.5 kDa, was mainly composed of mannose, glucose and galactose with mass percentages of 51.94%, 10.54%, and 37.25%, respectively. EPCM-2 is an a-pyran Creative Commons Attribution 3.0 Unported Licence. polysaccharide with an average molecular weight of 20 kDa that is mainly composed of mannose, glucose and galactose with mass percentages of 44.51%, 18.33%, and 35.38%, respectively. In in vivo study, EPCM-1 treatment (100 mg kgÀ1 dÀ1) showed potential effects on improving serum lipid profiles of hyperlipidemic mice, reflected by decreasing serum total cholesterol (TC), triglyceride (TG) and low density lipoprotein-cholesterol (LDL-C) levels by 20.05%, 45.45% and 52.63%, respectively, while IPCM-1 treatment
    [Show full text]
  • Table S1 the Four Gene Sets Derived from Gene Expression Profiles of Escs and Differentiated Cells
    Table S1 The four gene sets derived from gene expression profiles of ESCs and differentiated cells Uniform High Uniform Low ES Up ES Down EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol 269261 Rpl12 11354 Abpa 68239 Krt42 15132 Hbb-bh1 67891 Rpl4 11537 Cfd 26380 Esrrb 15126 Hba-x 55949 Eef1b2 11698 Ambn 73703 Dppa2 15111 Hand2 18148 Npm1 11730 Ang3 67374 Jam2 65255 Asb4 67427 Rps20 11731 Ang2 22702 Zfp42 17292 Mesp1 15481 Hspa8 11807 Apoa2 58865 Tdh 19737 Rgs5 100041686 LOC100041686 11814 Apoc3 26388 Ifi202b 225518 Prdm6 11983 Atpif1 11945 Atp4b 11614 Nr0b1 20378 Frzb 19241 Tmsb4x 12007 Azgp1 76815 Calcoco2 12767 Cxcr4 20116 Rps8 12044 Bcl2a1a 219132 D14Ertd668e 103889 Hoxb2 20103 Rps5 12047 Bcl2a1d 381411 Gm1967 17701 Msx1 14694 Gnb2l1 12049 Bcl2l10 20899 Stra8 23796 Aplnr 19941 Rpl26 12096 Bglap1 78625 1700061G19Rik 12627 Cfc1 12070 Ngfrap1 12097 Bglap2 21816 Tgm1 12622 Cer1 19989 Rpl7 12267 C3ar1 67405 Nts 21385 Tbx2 19896 Rpl10a 12279 C9 435337 EG435337 56720 Tdo2 20044 Rps14 12391 Cav3 545913 Zscan4d 16869 Lhx1 19175 Psmb6 12409 Cbr2 244448 Triml1 22253 Unc5c 22627 Ywhae 12477 Ctla4 69134 2200001I15Rik 14174 Fgf3 19951 Rpl32 12523 Cd84 66065 Hsd17b14 16542 Kdr 66152 1110020P15Rik 12524 Cd86 81879 Tcfcp2l1 15122 Hba-a1 66489 Rpl35 12640 Cga 17907 Mylpf 15414 Hoxb6 15519 Hsp90aa1 12642 Ch25h 26424 Nr5a2 210530 Leprel1 66483 Rpl36al 12655 Chi3l3 83560 Tex14 12338 Capn6 27370 Rps26 12796 Camp 17450 Morc1 20671 Sox17 66576 Uqcrh 12869 Cox8b 79455 Pdcl2 20613 Snai1 22154 Tubb5 12959 Cryba4 231821 Centa1 17897
    [Show full text]
  • Supplementary Data
    Supplemental Data A novel mouse model of X-linked nephrogenic diabetes insipidus: Phenotypic analysis and therapeutic implications Jian Hua Li, Chung-Lin Chou, Bo Li, Oksana Gavrilova, Christoph Eisner, Jürgen Schnermann, Stasia A. Anderson, Chu-Xia Deng, Mark A. Knepper, and Jürgen Wess Supplemental Methods Metabolic cage studies. Animals were maintained in mouse metabolic cages (Hatteras Instruments, Cary, NC) under controlled temperature and light conditions (12 hr light and dark cycles). Mice received a fixed daily ration of 6.5 g of gelled diet per 20 g of body weight per day. The gelled diet was composed of 4 g of Basal Diet 5755 (Test Diet, Richmond, IN), 2.5 ml of deionized water, and 65 mg agar. Preweighted drinking water was provided ad libitum during the course of the study. Mice were acclimated in the metabolic cages for 1-2 days. Urine was collected under mineral oil in preweighted collection vials for successive 24 hr periods. Analysis of GPCR expression in mouse IMCD cells via TaqMan real-time qRT-PCR. Total RNA prepared from mouse IMCD tubule suspensions was reverse transcribed as described under Experimental Procedures. Tissues from ten 10-week old C57BL/6 WT mice were collected and pooled for each individual experiment. cDNA derived from 640 ng of RNA was mixed with an equal volume of TaqMan gene expression 2 x master mix (Applied Biosystems, Foster City, CA). 100 μl-aliquots of this mixture (corresponding to 80 ng of RNA) were added to each of the 8 fill ports of a 384-well plate of a mouse GPCR array panel (Applied Biosystems).
    [Show full text]
  • TNAP As a New Player in Chronic Inflammatory Conditions And
    International Journal of Molecular Sciences Review TNAP as a New Player in Chronic Inflammatory Conditions and Metabolism Stephanie Graser 1,*, Daniel Liedtke 2,† and Franz Jakob 1,† 1 Bernhard-Heine-Center for Locomotion Research, Department of Orthopedics, Julius-Maximilians-University Würzburg, 97076 Würzburg, Germany; [email protected] 2 Institute for Human Genetics, Biocenter, Julius-Maximilians-University Würzburg, 97074 Würzburg, Germany; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: This review summarizes important information on the ectoenzyme tissue-nonspecific alkaline phosphatase (TNAP) and gives a brief insight into the symptoms, diagnostics, and treatment of the rare disease Hypophosphatasia (HPP), which is resulting from mutations in the TNAP encoding ALPL gene. We emphasize the role of TNAP beyond its well-known contribution to mineralization processes. Therefore, above all, the impact of the enzyme on central molecular processes in the nervous system and on inflammation is presented here. Keywords: TNAP; Hypophosphatasia; HPP; mineralization; nervous system; inflammation 1. Structure, Function, and Substrates of TNAP Tissue-nonspecific alkaline phosphatase (TNAP) or liver/bone/kidney alkaline phos- phatase is an ectoenzyme that is anchored to the outer cell membrane (e.g. in osteoblasts) Citation: Graser, S.; Liedtke, D.; and to extracellular vesicles via its glycosyl-inositol-phosphate (GPI)-anchor [1,2]. TNAP Jakob, F. TNAP as a New Player in belongs to the family of alkaline phosphatases (AP) that comprises in humans three addi- Chronic Inflammatory Conditions tional tissue-specific isoforms: placental (PLAP, ALPP National Center for Biotechnology and Metabolism. Int.
    [Show full text]
  • A Genetic Overview of Hypophosphatasia a Background in Genetics
    A Genetic Overview of Hypophosphatasia A Background in Genetics Cells are the basic building blocks of all living organisms. Our body is composed of trillions of cells. Each of these cells contains deoxyribonucleic acid (DNA), the hereditary material. DNA contains genetic instructions and tells the cell what to do and how to grow. DNA is stored in chromosomes. Humans have 23 pairs of chromosomes - a total of 46 - and each pair is labeled with its own number or letter for the X and Y sex chromosomes. Each set of chromosomes comes from each of our parents. » Cell Components Lisa Ormerod.1 Genes are located on chromosomes and determine our physical features. Genes are made up of DNA and they make molecules called proteins, the building blocks of all structures in the body. A Background in Genetics (continued) In the human body every gene contains a code that acts as a blueprint for the cell. Cells use this blueprint to make a certain protein that is necessary to keep our bodies healthy. Every person has two copies of each gene, one inherited from each parent. Genes are made up of combinations of nucleic acids: Adenine (A), Thymine (T), Cytosine (C) and Guanine (G). The genetic blueprint determines how these letters come together and form the DNA structure called the double helix, which resembles a twisted ladder. The order, or sequence, of these nucleic acids determines what biological instructions are contained in a strand of DNA, similar to how letters of the alphabet form words. » Nucleic Acids Cytosine Base pair Guanine Adenine Helix of sugar-phosphates Thymine Nucleobases of DNA DNA Deoxyribonucleic acid Adapted from: Chemical structures of nucleobases by Roland1952.2 » DNA Mutations Sometimes there are mistakes or changes in the pattern of letters in the DNA sequence.
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • Monitoring Nociception by Analyzing Gene Expression Changes in the Central Nervous System of Mice
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2010 Monitoring nociception by analyzing gene expression changes in the central nervous system of mice Asner, I N Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-46678 Dissertation Originally published at: Asner, I N. Monitoring nociception by analyzing gene expression changes in the central nervous system of mice. 2010, University of Zurich, Vetsuisse Faculty. Monitoring Nociception by Analyzing Gene Expression Changes in the Central Nervous System of Mice Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Igor Asner von St. Cergue VD Promotionskomitee Prof. Dr. Peter Sonderegger Prof. Dr. Kurt Bürki Prof. Dr. Hanns Ulrich Zeilhofer Dr. Paolo Cinelli (Leitung der Dissertation) Zürich, 2010 Table of contents Table of content Curriculum vitae 6 Publications 9 Summary 11 Zusammenfassung 14 1. Introduction 17 1.1. Pain and nociception 17 1.1.1 Nociceptive neurons and Mechanoceptors 18 1.1.2 Activation of the nociceptive neurons at the periphery 21 1.1.2.1 Response to noxious heat 22 1.1.2.2 Response to noxious cold 23 1.1.2.3 Response to mechanical stress 24 1.1.3 Nociceptive message processing in the Spinal Cord 25 1.1.3.1 The lamina I and the ascending pathways 25 1.1.3.2 The lamina II and the descending pathways 26 1.1.4 Pain processing and integration in the brain 27 1.1.4.1 The Pain Matrix 27 1.1.4.2 Activation of the descending pathways 29 1.1.5 Inflammatory Pain 31 1.2.
    [Show full text]
  • ADGRE2-NTF Is Regulated by Site- Specific N-Glycosylation
    www.nature.com/scientificreports OPEN Membrane-association of EMR2/ ADGRE2-NTF is regulated by site- specifc N-glycosylation Received: 19 December 2017 Yi-Shu Huang1,4, Nien-Yi Chiang1, Gin-Wen Chang1 & Hsi-Hsien Lin1,2,3 Accepted: 27 February 2018 The evolutionarily conserved adhesion G protein-coupled receptors (aGPCRs) play critical roles in Published: xx xx xxxx biological processes as diverse as brain development, cell polarity and innate immune functions. A defning feature of aGPCRs is the GPCR autoproteolysis inducing (GAIN) domain capable of self- catalytic cleavage, resulting in the generation of an extracellular N-terminal fragment (NTF) and a seven-transmembrane C-terminal fragment (CTF) involved in the cellular adhesion and signaling functions, respectively. Interestingly, two diferent NTF subtypes have previously been identifed, namely an NTF that couples non-covalently with the CTF and a membrane-associated NTF that tethers on cell surface independently. The two NTF subtypes are expected to regulate aGPCR signaling via distinct mechanisms however their molecular characteristics are largely unknown. Herein, the membrane-associated NTF of EMR2/ADGRE2 is investigated and found to be modifed by diferential N-glycosylation. The membrane association of EMR2-NTF occurs in post-ER compartments and site- specifc N-glycosylation in the GAIN domain is involved in modulating its membrane-association ability. Finally, a unique amphipathic α-helix in the GAIN domain is identifed as a putative membrane anchor of EMR2-NTF. These results provide novel insights into the complex interaction and activation mechanisms of aGPCRs. Characterized by a long extracellular domain (ECD) with cell-adhesion functions and a seven-transmembrane (7TM) domain with signaling functions, the adhesion G protein-coupled receptors (aGPCRs) have been impli- cated in diverse biological activities and human diseases1.
    [Show full text]
  • Functions of Nogo Proteins and Their Receptors in the Nervous System
    REVIEWS Functions of Nogo proteins and their receptors in the nervous system Martin E. Schwab Abstract | The membrane protein Nogo-A was initially characterized as a CNS-specific inhibitor of axonal regeneration. Recent studies have uncovered regulatory roles of Nogo proteins and their receptors — in precursor migration, neurite growth and branching in the developing nervous system — as well as a growth-restricting function during CNS maturation. The function of Nogo in the adult CNS is now understood to be that of a negative regulator of neuronal growth, leading to stabilization of the CNS wiring at the expense of extensive plastic rearrangements and regeneration after injury. In addition, Nogo proteins interact with various intracellular components and may have roles in the regulation of endoplasmic reticulum (ER) structure, processing of amyloid precursor protein and cell survival. Nogo proteins were discovered, and have been exten- The amino-terminal segments of the proteins sively studied, in the context of injury and repair of fibre encoded by the different RTN genes have differing tracts in the CNS1 — a topic of great research interest lengths and there is no homology between them3,5. The and clinical relevance. However, much less in known N termini of the RTN4 products Nogo-A and Nogo-B are about the physiological functions of Nogo proteins in identical, consisting of a 172-amino acid sequence that development and in the intact adult organism, including is encoded by a single exon (exon 1) that is followed by in the brain. Through a number of recent publications, a short exon 2 and, in Nogo-A, by the very long exon Nogo proteins have emerged as important regulators of 3 encoding 800 amino acids2,6 (FIG.
    [Show full text]
  • Detecting Remote, Functional Conserved Domains in Entire Genomes by Combining Relaxed Sequence-Database Searches with Fold Recognition
    HMMerThread: Detecting Remote, Functional Conserved Domains in Entire Genomes by Combining Relaxed Sequence-Database Searches with Fold Recognition Charles Richard Bradshaw1¤a, Vineeth Surendranath1, Robert Henschel2,3, Matthias Stefan Mueller2, Bianca Hermine Habermann1,4*¤b 1 Bioinformatics Laboratory, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Saxony, Germany, 2 Center for Information Services and High Performance Computing (ZIH), Technical University, Dresden, Saxony, Germany, 3 High Performance Applications, Pervasive Technology Institute, Indiana University, Bloomington, Indiana, United States of America, 4 Bioinformatics Laboratory, Scionics c/o Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Saxony, Germany Abstract Conserved domains in proteins are one of the major sources of functional information for experimental design and genome-level annotation. Though search tools for conserved domain databases such as Hidden Markov Models (HMMs) are sensitive in detecting conserved domains in proteins when they share sufficient sequence similarity, they tend to miss more divergent family members, as they lack a reliable statistical framework for the detection of low sequence similarity. We have developed a greatly improved HMMerThread algorithm that can detect remotely conserved domains in highly divergent sequences. HMMerThread combines relaxed conserved domain searches with fold recognition to eliminate false positive, sequence-based identifications. With an accuracy of 90%, our software is able to automatically predict highly divergent members of conserved domain families with an associated 3-dimensional structure. We give additional confidence to our predictions by validation across species. We have run HMMerThread searches on eight proteomes including human and present a rich resource of remotely conserved domains, which adds significantly to the functional annotation of entire proteomes.
    [Show full text]